Alto Ingredients (ALTO) Misses Q4 EPS by 63c

Alto Ingredients (NASDAQ: ALTO) reported Q4 EPS of ($0.57), $0.63 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $236.3 million versus the consensus estimate of $268.62 million.

For earnings history and earnings-related data on Alto Ingredients (ALTO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c